Radiolabeled Acridine Orange (AO) Derivatives as DNA-Targeted Probes for Auger Therapy

被引：0
|
作者：
Pereira, E. [1 ]
Quental, L. [1 ]
Oliveira, M. C. [1 ]
Raposinho, P. [1 ]
Belchior, A. [1 ]
Di Maria, S. [1 ]
Correia, I. [2 ]
Lavrado, J. [3 ]
Mendes, F. [1 ]
Vaz, P. [1 ]
Santos, Isabel [1 ]
Paulo, A. [1 ]
机构：
[1] Univ Lisbon, Ctr Ciencias & Tecnol Nucl, IST, Estr Nacl 10, P-2695066 Bobadela Lrs, Portugal
[2] Univ Lisbon, Ctr Quim Estrutural, IST, Ave Rovisco Pais 1, P-1049001 Lisbon, Portugal
[3] Univ Lisbon, IMed ULisboa, Fac Farm, Ave Prof Gama Pinto, P-1649003 Lisbon, Portugal
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
170
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 45 条
  • [1] Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA
    Edgar Pereira
    Letícia do Quental
    Elisa Palma
    Maria Cristina Oliveira
    Filipa Mendes
    Paula Raposinho
    Isabel Correia
    João Lavrado
    Salvatore Di Maria
    Ana Belchior
    Pedro Vaz
    Isabel Santos
    António Paulo
    Scientific Reports, 7
  • [2] Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA
    Pereira, Edgar
    do Quental, Leticia
    Palma, Elisa
    Oliveira, Maria Cristina
    Mendes, Filipa
    Raposinho, Paula
    Correia, Isabel
    Lavrado, Joao
    Di Maria, Salvatore
    Belchior, Ana
    Vaz, Pedro
    Santos, Isabel
    Paulo, Antonio
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Comparative analysis of auger electron emission libraries and Monte Carlo track structure codes for DNA-targeted auger electron therapy
    Velo, Alexandre Franca
    Carter, Lukas
    Bellamy, Michael
    Zeglis, Brian M.
    Humm, John L.
    MEDICAL PHYSICS, 2025,
  • [4] Cytotoxic and DNA-Targeted Therapy in Urothelial Cancer
    Balar, Arjun V.
    Milowsky, Matthew I.
    CANCER, 2015, 121 (02) : 179 - 187
  • [5] Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma
    Gardette, Maryline
    Viallard, Claire
    Paillas, Salome
    Guerquin-Kern, Jean-Luc
    Papon, Janine
    Moins, Nicole
    Labarre, Pierre
    Desbois, Nicolas
    Wong-Wah-Chung, Pascal
    Palle, Sabine
    Wu, Ting-Di
    Pouget, Jean-Pierre
    Miot-Noirault, Elisabeth
    Chezal, Jean-Michel
    Degoul, Francoise
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (04) : 587 - 597
  • [6] Evaluation of two 125I-radiolabeled acridine derivatives for Auger-electron radionuclide therapy of melanoma
    Maryline Gardette
    Claire Viallard
    Salomé Paillas
    Jean-Luc Guerquin-Kern
    Janine Papon
    Nicole Moins
    Pierre Labarre
    Nicolas Desbois
    Pascal Wong-Wah-Chung
    Sabine Palle
    Ting-Di Wu
    Jean-Pierre Pouget
    Elisabeth Miot-Noirault
    Jean-Michel Chezal
    Francoise Degoul
    Investigational New Drugs, 2014, 32 : 587 - 597
  • [7] Role of Akt signaling in resistance to DNA-targeted therapy
    Avan, Abolfazl
    Narayan, Ravi
    Giovannetti, Elisa
    Peters, Godefridus J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (05): : 352 - 369
  • [8] Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with 177Lu-Acridine
    Ghosh, Subhajit
    Das, Tapas
    Suman, Shishu K.
    Kumar, Chandan
    Sarma, Haladhar D.
    Dash, Ashutosh
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [9] DNA interaction and photonicking properties of DNA-targeted acridine (2,2′-bipyridine)platinum(II) complexes
    Gude, L
    Fernández, MJ
    Grant, KB
    Lorente, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3135 - 3139
  • [10] Discovery of a Chiral DNA-Targeted Platinum-Acridine Agent with Potent Enantioselective Anticancer Activity
    Zhang, Shenjie
    Yao, Xiyuan
    Watkins, Noah H.
    Rose, P. Keegan
    Caruso, Sofia R.
    Day, Cynthia S.
    Bierbach, Ulrich
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (49) : 21965 - 21970
12345